Prevention of cardiovascular disease in women

被引:0
|
作者
Omer L. Shedd
Marian C. Limacher
机构
[1] University of Florida College of Medicine,Division of Cardiovascular Medicine, Department of Medicine
关键词
Bile Acid; Niacin; American Heart Association; Ezetimibe; Main Side Effect;
D O I
10.1007/s11936-003-0028-6
中图分类号
学科分类号
摘要
Appropriate screening and lifestyle modification are the foundations of effective cardiovascular disease (CVD) prevention in women. All adult women should undergo a cardiovascular risk assessment, including family history, smoking, diet, and exercise assessments, and measurement of fasting lipid profile, waist and hip dimensions, and blood pressure. Women should be advised of their 10-year estimated risk of developing a cardiovascular event using the Framingham risk calculator as recommended by the National Cholesterol Education Program. Based on the level of risk, women should receive counseling on dietary modification, physical activity, weight loss, and the need for pharmacologic intervention for blood pressure, lipid, and diabetes management. In addition, women who are overweight, have a history of gestational diabetes, or family history of diabetes should have a fasting glucose measured. Women who smoke should receive advice, encouragement, and assistance for smoking cessation. Postmenopausal hormone therapy should not be considered a treatment option for primary or secondary prevention of CVD. Women and their families should be advised of the possible signs of CVD and the need to seek immediate medical attention in the event of prolonged, new, or severe symptoms. Women with coronary artery disease especially need close attention to their risk factor levels and should receive intensive intervention to achieve optimal control.
引用
收藏
页码:287 / 298
页数:11
相关论文
共 50 条
  • [21] Women, menopause and the primary prevention of cardiovascular disease
    Bonita, R
    VASCULAR DISEASE IN THE ELDERLY, 1998, : 73 - 89
  • [22] Aspirin for the Primary Prevention of Cardiovascular Disease in Women
    Bailey A.L.
    Campbell C.L.
    Smyth S.S.
    Current Cardiovascular Risk Reports, 2010, 4 (3) : 209 - 215
  • [23] Cardiovascular disease in women: Prevention, symptoms, diagnosis, pathogenesis
    Naderi, Sahar
    Cho, Leslie S.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2013, 80 (09) : 577 - 587
  • [24] Dyslipidemia, Risk Factors, and the Prevention of Cardiovascular Disease in Women
    Kones, Richard
    Rumana, Umme
    JOURNAL OF WOMENS HEALTH, 2013, 22 (05) : 402 - 403
  • [25] Inadequate cardiovascular disease prevention in women with physical disabilities
    Capriotti, T
    REHABILITATION NURSING, 2006, 31 (03) : 94 - 101
  • [26] Recommendations for Cardiovascular Disease Prevention in Women: An Indian Perspective
    Khan, Zakia
    Rao, Sarita
    Bhatia, Ritu
    Ray, Saumitra
    Dalal, Jamshed J.
    JOURNAL OF THE PRACTICE OF CARDIOVASCULAR SCIENCES, 2023, 9 (01) : 11 - 17
  • [27] Heartbeat: diet and primary prevention of cardiovascular disease in women
    Otto, Catherine M.
    HEART, 2023, 109 (16) : 1193 - 1195
  • [28] Attitudes and behaviour of women towards cardiovascular disease prevention
    Ruiz Martil, Carmen Amelia
    Pizarro Losilla, Belen
    Perez Castro, Margarita
    Rios German, Peggy Paola
    Lopez de Castro, Francisco
    ENFERMERIA CLINICA, 2011, 21 (04): : 196 - 201
  • [29] Aspirin for the Primary Prevention of Atherosclerotic Cardiovascular Disease in Women
    Shufelt, Chrisandra L.
    Mora, Samia
    Manson, JoAnn E.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (07): : 672 - 673
  • [30] Cardiovascular disease prevention in women - the current state in 2023
    Purohit, Aarti
    Kim, Yoo Jin
    Michos, Erin D.
    CURRENT OPINION IN CARDIOLOGY, 2024, 39 (01) : 54 - 60